LigaChem Biosciences Inc. Logo

LigaChem Biosciences Inc.

Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.

141080 | KO

Overview

Corporate Details

ISIN(s):
KR7141080002
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학10로 10 (주)레고켐 바이오사이언스, 대전광역시

Description

LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative medicines. Leveraging its core expertise in medicinal chemistry, the company focuses on developing Antibody-Drug Conjugates (ADCs), immuno-oncology drugs, and small molecules. A key asset is its proprietary, next-generation ADC platform technology, engineered to overcome the limitations of conventional ADC technologies. The company's pipeline includes multiple programs targeting oncology, as well as other therapeutic areas such as antibiotics and anti-fibrotics. LigaChem Biosciences actively pursues global drug development through strategic partnerships, including co-development and licensing agreements with international pharmaceutical companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-26 00:00
주식등의대량보유상황보고서(약식)
Korean 55.6 KB
2024-03-21 00:00
감사보고서제출
Korean 26.0 KB
2024-03-21 00:00
사업보고서 (2023.12)
Korean 1.9 MB
2024-03-14 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.9 KB
2024-03-14 00:00
주주총회소집공고
Korean 175.4 KB
2024-03-12 00:00
주주총회소집결의
Korean 18.3 KB
2024-03-12 00:00
주주총회집중일개최사유신고
Korean 5.4 KB
2024-01-25 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.4 KB
2024-01-19 00:00
기업설명회(IR)개최
Korean 7.1 KB
2024-01-19 00:00
[기재정정]기업설명회(IR)개최
Korean 10.9 KB
2024-01-17 00:00
주식등의대량보유상황보고서(일반)
Korean 80.9 KB
2024-01-17 00:00
주식등의대량보유상황보고서(일반)
Korean 106.0 KB
2024-01-15 00:00
주요사항보고서(유상증자결정)
Korean 31.6 KB
2024-01-15 00:00
최대주주변경을수반하는주식양수도계약체결
Korean 21.1 KB
2024-01-08 00:00
주식등의대량보유상황보고서(약식)
Korean 65.2 KB

Automate Your Workflow. Get a real-time feed of all LigaChem Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LigaChem Biosciences Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LigaChem Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.